Global 3D bioprinting market is
expected to reach USD 1.82 billion by 2022, according to a new report by Grand
View Research Inc. Rising prevalence of chronic diseases such as Chronic Kidney
Disease (CKD) which demands kidney transplantation is expected to boost the
market growth, as 3D bioprinting is convenient and cost effective substitute
for organ transplantation.
Emerging medical
applications of 3D bioprinting such as toxicity testing, drug discovery, tissue
engineering and consumer product testing are expected to further drive the
market growth positively. Increasing R&D expenditure is anticipated to be
high impact rendering driver for the industry. 3D bioprinting advances in
tissue engineering and allows developments to be done using biomaterials which
have better biocompatibility. Moreover, rising geriatric population is expected
to assist the market growth, as this demographic is highly susceptible to age
related organ deformities.
Browse full report by Grand View
Research :
Further key findings from the study suggest:
·
Syringe based printers dominated the
technology segment as these printers allow working in sterile environment.
Moreover, syringe based printers have wide applications which include
fabrication of scaffolds, cell strips printing, and tissue printing.
·
Magnetic levitation based printers are
expected to witness lucrative growth over the forecast period. This can be
attributed to emerging medical applications such as screening of cardiovascular
toxicity, human cell modeling and smooth muscle printing.
·
The medical applications segment is
expected to gain substantial share of over 32.0% by 2022 which can be
attributed to emerging applications of 3D bioprinting such as toxicity
screening, organ transplants and medical pills.
·
Dental application segment is expected to
witness lucrative growth over the forecast period. Rising demand for cosmetic
dentistry along with growing awareness about oral hygiene are expected to
foster the demand for dental applications.
·
North America dominated the regional 3D
bioprinting market with over 35.0% share and is expected to grow at a CAGR of
10.0%. Supportive government initiatives to improve healthcare infrastructure
coupled with growing disposable income are vital driving factor for this
region’s growth.
·
Asia Pacific is expected to witness
lucrative growth over the forecast period. Favorable government support to
improve healthcare delivery with economic developments in emerging countries
such as India and China are expected to increase the demand for 3D bioprinting.
·
Key players operating in the 3D bioprinting
industry include Organovo Holding Inc., Cyfuse Biomedical, BioBots, Luxexcel
Group BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics Systems, Stratasys
Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC, Bio3D Technologies, Solidscape
and others.
·
These players are involved in various
strategic initiatives such as new product launches, strategic alliances and
mergers and acquisitions to gain the edge over the competitors. For instance,
In June 2015, Orgonovo collaborated with L’Oreal to develop skin tissue using
NovoGen Bioprinting platform.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has
segmented the global 3D bioprinting market on the basis of products and region:
3D Bioprinting Market Technology Outlook (USD
million), 2012 - 2022
·
Magnetic levitation
·
Inkjet based
·
Syringe based
·
Laser based
·
Other
3D Bioprinting Market Application Outlook (USD million),
2012 - 2022
·
Medical
o Tissue and organ generation
o Medical pills
o Prosthetics and implants
·
Dental
·
Biosensors
·
Consumer/Personal products testing
·
Bioinks
·
Food and animal product bioprinting
3D Bioprinting Market Regional Outlook (USD million),
2012 - 2022
·
North America
o U.S.
o Canada
·
Europe
o UK
o Germany
·
Asia Pacific
o Japan
o China
·
Latin America
o Brazil
·
MEA
o South Africa.
View Press Release of this research report by Grand View Research:
http://www.grandviewresearch.com/press-release/global-3d-bioprinting-market
About
Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For
More Information: www.grandviewresearch.com